Document:

Warrant to Purchase Series C Convertible Preferred Stock (No. C2-01)

 Exhibit 10.19 
 THE SECURITIES EVIDENCED BY AND UNDERLYING THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY NOT BE SOLD, TRANSFERRED,
ASSIGNED OR HYPOTHECATED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT COVERING SUCH SECURITIES OR IF THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF SUCH SECURITIES REASONABLY SATISFACTORY TO THE
COMPANY, STATING THAT SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE SECURITIES ACT. 
  

			
	Warrant No. C2-01	 	July 19, 2006

WARRANT TO PURCHASE SERIES C CONVERTIBLE PREFERRED STOCK 
 OF AUTOGENOMICS, INC. 
 This warrant (the “Warrant”)
certifies that Robert A. Levin (the “Holder”) and the Holder’s registered successors and assigns are entitled, subject to the terms and conditions set forth below, to subscribe for and purchase from AutoGenomics, Inc., a
California corporation (the “Company”). Four Thousand Three Hundred Sixty-Four (4,364) shares (the “Warrant Shares”) of Series C Convertible Preferred Stock of the Company (the “Series C Preferred
Stock”) at an exercise price of $2.75 per share (the “Exercise Price”). This Warrant is issued pursuant to that certain Series C Convertible Preferred Stock Purchase Agreement, dated as of July 19, 2006, among the
Company, the Holder and certain other parties (the “Purchase Agreement”). 
 1. Exercise and Expiration.

 1.1 Expiration Method of Exercise. This Warrant may be exercised in whole or in part at any time or times prior to
July 19, 2013, at which time this Warrant shall expire (the “Expiration Date”). In the event Holder exercises this Warrant in part, but not in whole, Holder shall be entitled to exercise this Warrant for the lesser of
(a) 1,000 Warrant Shares or (b) the maximum number of Warrant Shares then available for exercise. This Warrant shall be exercised by surrender hereof together with delivery of a signed Subscription Agreement in the form attached hereto as
Annex I (the “Subscription Agreement”) specifying the number of shares of Series C Preferred Stock to be purchased. 
 1.2 Payment. Payment of the Exercise Price for the shares of Series C Preferred Stock to be purchased shall be made upon the delivery of certificates evidencing the shares of Series C Preferred
Stock to be purchased, and shall be made in cash, or by wire transfer or check. Upon any such purchase, the number of Warrant Shares purchasable upon exercise of this Warrant shall be reduced by the number of shares being purchased, and, if a
balance of purchasable securities remains after such exchange, the Company shall execute and deliver to the Holder a new Warrant evidencing the right of the Holder to purchase such balance of securities. Such purchase shall be effective immediately
prior to the close of business on the date of receipt by the Company of the original Warrant surrendered for cancellation together with delivery of a signed Subscription Agreement and payment of the Exercise Price for the shares being purchased, or,
if later, at such other date as may be specified by written request. 

 1.3 Conditional Net Exercise. 

(a) If the Company’s Restated Articles (as such term is defined in Section 5.3 of the Purchase Agreement) are adopted and
approved by the shareholders of the Company at the 2006 annual meeting of such shareholders, the provisions of Section 1.3(b) hereof shall, effective as of the filing of the Restated Articles with the Secretary of State of the State of
California, be deemed effective. If the Restated Articles are not adopted and approved by the shareholders of the Company, the provisions of Section 1.3(b) shall be deemed stricken from this Warrant and shall be of no force or effect.

 (b) This Section 1.3(b) shall not be deemed part of this Warrant, and the provisions hereof shall not be deemed
effective, unless and until the Restated Articles are filed with the Secretary of State of the State of California. Effective as of such filing (if any) of the Restated Articles, as an alternative to payment pursuant to Section 1.2
hereof, the Holder shall have the right, upon its written request delivered or transmitted to the Company together with this Warrant, to exchange this Warrant, in whole or in part at any time or from time to time on or prior to the Expiration Date,
for the number of Warrant Shares having an aggregate Fair Market Value (determined as set forth in Section 1.4 below) on the date of such exchange equal to the difference between (i) the aggregate Fair Market Value on the date of
such exchange of a number of Warrant Shares designated by the Holder and (ii) the aggregate Exercise Price the Holder would have paid to the Company to purchase such designated number of Warrant Shares upon exercise of this Warrant. Upon any
such exchange, the number of Warrant Shares purchasable upon exercise of this Warrant shall be reduced by such designated number of shares, and, if a balance of purchasable securities remains after such exchange, the Company shall execute and
deliver to the Holder a new Warrant evidencing the right of the Holder to purchase such balance of securities. No payment of any cash or other consideration shall be required. Such exchange shall be effective immediately prior to the close of
business on the date of receipt by the Company of the original Warrant surrendered for cancellation, together with a written request from the Holder that the exchange pursuant to this Section be made and delivery of a signed Subscription Agreement,
or, if later, at such other date as may be specified in such written request. 
 1.4 Fair Market Value. Fair market value
of the Warrant Shares (“Fair Market Value”) shall be determined as follows: 
 (a) If the Warrant Shares are
listed on a national securities exchange or admitted to unlisted trading privileges on such an exchange, or are listed on the Nasdaq National Market or Small Cap Market, the current Fair Market Value shall be the last reported sales price of the
Warrant Shares on such exchange or Nasdaq on the last business day prior to the date of exercise of this Warrant or if no such sale is made on such day, the mean of the closing bid and asked prices for such day on such exchange or Nasdaq; or

 (b) If the Warrant Shares are not so listed or admitted to unlisted trading privileges or quoted on Nasdaq, the current Fair
Market Value shall be the mean of the last bid and asked prices reported on the last business day prior to the date of the exercise of this Warrant (i) by Nasdaq, or (ii) if reports are unavailable under clause (i) above, by the
National Quotation Bureau Incorporated; or 

  
 2 

 (c) If the Warrant Shares are not so listed or admitted to unlisted trading privileges and
bid and asked prices are not so reported, the current Fair Market Value shall be determined in good faith by the Board of Directors of the Company. 
 2. Adjustment of Exercise Price and Number of Shares. The Exercise Price and the number of shares purchasable upon the exercise of this Warrant shall be subject to adjustment from time to time upon
the occurrence of certain events described in this Section 2. 
 2.1 Stock Dividends, Splits. If, after the
date hereof, the Company shall (i) pay a dividend or make a distribution in shares of capital stock (whether shares of Common Stock or capital stock of any other class), (ii) effect a stock split or subdivide its outstanding Warrant
Shares, (iii) effect a reverse stock split or combine its outstanding Warrant Shares into a smaller number of shares, or (iv) effect any other reclassification or recapitalization, the Exercise Price in effect immediately prior thereto
shall be adjusted so that upon the subsequent exercise of this Warrant the Holder hereof shall be entitled to receive the number of shares or other units of equity securities of the Company which the Holder hereof would have owned or have been
entitled to receive after the happening of any of the events described above had such Warrant been exercised immediately prior to the happening of such event. An adjustment made pursuant to this Section 2.1 shall become effective
immediately after the record date for any event requiring such adjustment or shall become effective immediately after the effective date of such event if no record date is set. 

2.2. Adjustment of Warrant Shares. Upon each adjustment of the Exercise Price pursuant to Section 2.1, the holder of
this Warrant shall thereafter be entitled to purchase, at the Exercise Price resulting from such adjustment, the number of Warrant Shares obtained by multiplying the Exercise Price in effect immediately prior to such adjustment by the number of
Warrant Shares purchasable pursuant hereto immediately prior to such adjustment; and dividing the product thereof by the Exercise Price resulting from such adjustment. 
 2.3 Notice. Whenever the Exercise Price is adjusted, as herein provided, the Company shall promptly prepare a notice of such adjustment of the Exercise Price setting forth the adjusted Exercise
Price, the number of shares issuable upon exercise of the Warrant and the date on which such adjustment becomes effective and shall mail such notice of such adjustment of the Exercise Price to the holder of this Warrant at the address of such Holder
as in the records of the Company. 
 2.4 No Impairment. Except pursuant to an action properly taken under the
Company’s Amended and Restated Articles of Incorporation, the Company will not, by amendment of its Articles of Incorporation or through any consolidation, merger, reorganization, transfer of assets, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms herein, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate in order to protect the rights of the Holder against dilution or other impairment. 
 3. Reservation of
Warrant Shares. The Company hereby covenants and agrees that it shall at all times reserve and keep authorized and available for issuance, free of any preemptive rights or rights of first refusal, a sufficient number of Warrant Shares for the
purpose of issuance upon exercise of this Warrant to permit the exercise of this Warrant in whole. 

  
 3 

 4. Loss, Etc. of Warrant. Upon receipt of evidence satisfactory to the Company of the
loss, theft, destruction or mutilation of this Warrant, and of indemnity reasonably satisfactory to the Company, if lost, stolen or destroyed, and upon surrender and cancellation of this Warrant, if mutilated, the Company shall execute and deliver
to the Holder a new Warrant of like date, tenor and denomination. 
 5. Warrant Holder Not Shareholder. Except as
otherwise provided herein, this Warrant does not confer upon the Holder any right to vote or to consent to or receive notice as a shareholder of the Company, as such, in respect of any matters whatsoever, or any other rights or liabilities as a
shareholder, prior to the exercise hereof. 
 6. Disposition of Warrant or Warrant Shares. The Holder, by acceptance
hereof, acknowledges and agrees that this Warrant and the Warrant Shares shall be subject to certain restrictions on disposition and legend requirements set forth in Section 3 of the Purchase Agreement and on the first page of this Warrant.

 7. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon
the exercise of this Warrant, but in lieu of such fractional shares the Company shall make a cash payment therefor on the basis of the Exercise Price then in effect. 
 8. Miscellaneous. 
 8.1 Notices. All notices required under this
Warrant and shall be deemed to have been given or made for all purposes (a) upon personal delivery, (b) one (1) business day after being sent, when sent by professional overnight courier service, or (c) three (3) days after
posting when sent by registered or certified mail. Notices to the Company shall be sent to the principal office of the Company (or at such other place as the Company shall notify the Holder hereof in writing). Notices to the Holder shall be sent to
the address of the Holder on the books of the Company (or at such other place as the Holder shall notify the Company hereof in writing). 
 8.2 Headings. The headings of this Warrant have been inserted as a matter of convenience and shall not affect the construction hereof. 

8.3 Applicable Law. This Warrant shall be governed by and construed in accordance with the law of the State of California without
giving effect to the principles of conflicts of law thereof. 
 8.4 Amendment. Any term of this Warrant may be amended
and the observance of any term of this Warrant may be waived with the written consent of the Company and the Holder. Any waiver or amendment effected in accordance with this Section 8.4 shall be binding upon each holder of any shares
purchased under this Warrant at the time outstanding (including securities into which such shares have been converted), each future holder of all such shares, and the Company. 
 8.5 Registration Rights, “Market Stand-Off’ Agreement. The Company acknowledges and agrees that it has granted registration rights to the Holder for Common Stock of the Company issued or
issuable upon conversion of the Warrant Shares pursuant to that certain Registration Rights Agreement, dated July 19, 2006 (the “Registration Rights Agreement”), among the Company, the Holder and certain other parties. The
Holder acknowledges and agrees that the Holder is subject to the “market stand-off” provision set forth in Section 2.12 of the Registration Rights Agreement. 

  
 4 

 [remainder of this page intentionally left blank] 

  
 5 

 IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed and delivered by
its duly authorized officer as of the      day of July, 2006. 
  

	
	COMPANY:
	
	 AUTOGENOMICS, INC.,
 a
California corporation

	
	 /s/ Fareed Kureshy

	Fareed Kureshy, President & CEO

  
 6 

 Schedule to Exhibit 10.20 

The following preferred stock warrants are substantially identical in all material respects to the representative warrant to which this
schedule is attached and which is filed as an exhibit to AutoGenomics, Inc.’s registration statement on Form S-1 (Reg. No. 333-152512) (the “Registration Statement”), except as to the parties thereto, dates of issuance, number of
warrant shares and expiration dates set forth below. These other preferred stock warrants are not being filed with the Registration Statement, pursuant to Instruction 2 to Item 601 of Regulation S-K promulgated under the Securities Exchange Act
of 1934, as amended. 
  

									
	 Number
	  	 Holder
	  	 Date of Issuance
	  	Warrant Shares	  	 Expiration Date

	 C2-02
	  	IRA FBO Kevin A. Doyle, Pershing LLC, Custodian	  	July 19, 2006	  	1,818	  	July 19, 2013
	 C2-03
	  	IRA FBO Bradley A. Danielson, Pershing LLC, Custodian	  	July 19, 2006	  	7,273	  	July 19, 2013
	 C2-06
	  	The Danielson Family Trust	  	July 19, 2006	  	10,909	  	July 19, 2013
	 C2-09
	  	William H. Davidson	  	July 19, 2006	  	7,273	  	July 19, 2013
	 C2-11
	  	Charles Tobias Switzer	  	July 19, 2006	  	7,273	  	July 19, 2013
	 C2-14
	  	 Bantam Group LLC
	  	July 19, 2006	  	1,818	  	July 19, 2013
	 C2-15
	  	Joseph P. Sullivan	  	July 19, 2006	  	3,636	  	July 19, 2013
	 C2-16
	  	Dennis D. Curtin and Karen E. Hogan-Curtin	  	July 19, 2006	  	2,182	  	July 19, 2013
	 C2-18
	  	Roger Ian MacFarlane	  	July 19, 2006	  	72,727	  	July 19, 2013
	 C2-19
	  	Warren H. Lortie Trust	  	July 19, 2006	  	18,182	  	July 19, 2013
	 C2-20
	  	Michael M. Rue, Trustee	  	July 19, 2006	  	10,909	  	July 19, 2013
	 C2-21
	  	Treagale Group Limited	  	July 19, 2006	  	109,091	  	July 19, 2013
	 C2-22
	  	A R Properties C/O Dennis A. Repp	  	August 18, 2006	  	14,545	  	July 19, 2013
	 C2-25
	  	The Tolkoff Family Limited Partnership II	  	July 19, 2006	  	4,000	  	July 19, 2013
	 C2-26
	  	Karen L. Danielson	  	October 27, 2006	  	5,091	  	July 19, 2013

									
	 C2-27
	  	Camden C. Danielson	  	October 27, 2006	  	2,182	  	July 19, 2013
	 C2-28
	  	The Self-Directed Retirement Account of Karen L. Danielson	  	October 27, 2006	  	10,181	  	July 19, 2013
	 C2-29
	  	The Self-Directed Retirement Account of Camden C. Danielson	  	October 27, 2006	  	4,364	  	July 19, 2013
	 C2-30
	  	William H. Davidson	  	December 29, 2006	  	10,000	  	December 29, 2013
	 C2-31
	  	Harold F. McGrath, as Trustee of the McGrath Family Trust	  	July 17, 2008	  	10,909	  	August 18, 2013Warrant to Purchase Common Stock (No. E-01)

 Exhibit 10.20 
 THE SECURITIES REPRESENTED BY AND UNDERLYING THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER ANY APPLICABLE STATE SECURITIES LAWS. SUCH
SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A CURRENT AND EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS WITH RESPECT TO
SUCH SECURITIES, OR AN OPINION SATISFACTORY TO THE ISSUER AND ITS COUNSEL TO THE EFFECT THAT SUCH REGISTRATION IS NOT REQUIRED. 
  

	 WARRANT NO. E-01
	 November 29, 2011 

 WARRANT TO PURCHASE COMMON STOCK 
 AutoGenomics, Inc. a Delaware corporation (the
“Company”), hereby certifies that Roland F. Smith (the “Holder”), is entitled to purchase, on the terms and conditions contained herein, one hundred fifty thousand (150,000) of the fully paid, validly issued
and nonassessable shares (the “Warrant Shares”) of the Company’s Common Stock, par value $0.01 per share (the “Common Stock”), at the exercise price set forth in Section 2 below (the “Exercise
Price”). This Warrant has been issued pursuant to that certain Subscription Agreement of even date herewith by and between the Company and the Holder (the “Agreement”). 

This Warrant is subject to the following terms and conditions: 
 1. Exercisability and Exercise. 
 1.1 Method of Exercise. This
Warrant may be exercised, in whole or in part, at the option of the Holder at any time and from time to time during the period commencing on the date hereof and ending on the close of business of the date that is the five (5) year anniversary
of the date hereof (the “Expiration Date”), by delivering the following to the Company at its address set forth below (or at such other address as it may designate by notice in writing to the Holder): 

a) Payment of the aggregate Exercise Price for the Common Stock to be purchased thereby by (i) check or wire transfer,
(ii) cancellation of indebtedness, or (iii) surrender of purchase rights under this Warrant; 
 b) An executed Notice
of Exercise in the form attached hereto as Exhibit I indicating the number of shares Holder desires to purchase; and 
 c) This
Warrant. 
 Each right to purchase a share of Common Stock that is so surrendered pursuant to Section 1.1(a) shall be payment of that
portion of the purchase price for a share of the Common Stock equal to the difference between (1) the fair market value of a share of Common Stock on the applicable exercise date (and if same shall not be readily available then such fair market
value shall be as determined in good faith by the Board of Directors of the Company) and (2) the exercise price for the share of Common Stock under the purchase right surrendered. 

1.2 Effectiveness of Exercise; Procedure. The exercise of this Warrant shall be deemed to have been effected immediately prior to
the close of business on the day on which the Holder delivers the Notice of Exercise to the Company together with payment of the Exercise Price and satisfies all of the requirements of this Section 1. Upon such exercise, the Holder will be
deemed a shareholder of record of those Warrant Shares for which this Warrant has been exercised with all rights of a shareholder (including, without limitation, all voting rights with respect to such Warrant Shares and all rights to receive any
dividends with respect to such Warrant Shares). In the event of any exercise of the rights represented by this Warrant, certificates for the shares of Common Stock so purchased shall be delivered

  
 - 1 -

 
to the Holder within a reasonable time. The Company shall not be required to issue fractional shares upon the exercise of this Warrant. In lieu of any fractional share to which the Holder would
otherwise be entitled, the Holder shall be entitled, at its option, to receive either (a) a cash payment equal to the excess of the fair market value, as determined by the Board of Directors of the Company in good faith, for such fractional
share above the Exercise Price for such fractional share (as mutually determined by the Company and the Holder) or (b) a whole share if the Holder tenders the Exercise Price for one whole share. 

2. Exercise Price. The Exercise Price for each share of Common Stock hereunder shall be Two and 75/100 Dollars ($2.75), subject to
adjustment pursuant to Section 3 below. 
 3. Adjustments. 

3.1 Reorganizations, Mergers, Recapitalizations and Reclassifications. The Exercise Price per Warrant Share and the number of
Warrant Shares purchasable hereunder shall be subject to adjustment from time to time as follows: 
 (a) Merger. If at
any time there shall be a merger, acquisition or consolidation of the Company with or into another corporation or a sale of all or substantially all of the Company’s assets, then, as a part of such merger, acquisition, consolidation or sale,
lawful provision shall be made so that the holder of this Warrant shall automatically receive upon the effectiveness of such transaction, the number of shares of stock or other securities or assets or property of the successor corporation resulting
from such merger, consolidation, acquisition or sale, to which a holder of the stock deliverable upon exercise of this Warrant would be entitled in such merger, consolidation, acquisition or sale upon exercise of this Warrant immediately before such
transaction, less the value of the Exercise Price for such Warrant then in effect. 
 (b) Reclassification, etc. If the
Company shall, at any time, by subdivision, combination, reorganization or reclassification of securities or otherwise, change any of the securities issuable upon exercise of this Warrant into the same or a different number of securities of any
other class or classes, the provisions of this Warrant shall be adjusted such that this Warrant shall thereafter represent the right to acquire such number and kind of securities as would have been issuable as the result of such change with respect
to the securities which were subject to the purchase rights under this Warrant immediately prior to such subdivision, combination, reclassification or other change. 
 (c) Split, Subdivision or Combination of Shares. If the Company at any time while this Warrant remains outstanding and unexpired shall split, subdivide or combine the securities issuable upon
exercise of this Warrant, the Exercise Price shall be proportionately decreased in the case of a split or subdivision or proportionately increased in the case of a combination. 

(d) Other events. If any change in the outstanding Common Stock of the Company or any other event occurs as to which the
provisions of this Section 3.1 are not strictly applicable and, in the reasonable opinion of the Company, would not fairly protect the purchase rights of the Holder in accordance with the essential intent and principles of such provisions, then
the Board of Directors of the Company shall make an adjustment in the number and class of shares purchasable upon the exercise of this Warrant or the application of such provisions, so as to protect such purchase rights as aforesaid. The adjustment
shall be such as will give the Holder upon exercise for the same aggregate stock purchase price the total number, class and kind of shares as the Holder would have owned had this Warrant been exercised prior to the event and had the Holder continued
to hold such shares until after the event requiring adjustment. 
 3.2 Notice of Adjustment. Upon the occurrence of each
adjustment or readjustment of the Exercise Price or the number and kind of securities into which this Warrant is exercisable, the Company at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and
furnish to the Holder a certificate setting forth such adjustment or readjustment (including the kind and amount of securities, cash or other property for which this Warrant shall be 

  
 - 2 -

 
exercisable and the Exercise Price) and showing in detail the facts upon which such adjustment or readjustment is based. The Company shall, upon the written request at any time of the Holder,
furnish or cause to be furnished to the Holder a certificate setting forth (i) the Exercise Price then in effect and (ii) the number and kind of shares of capital stock and the amount, if any, of other securities, cash or property which
then would be received upon the exercise of this Warrant. 
 4. Reservation of Common Stock. The Company shall at all
times have authorized, and reserved for the purpose of the issue upon exercise of this Warrant, a sufficient number of shares of its Common Stock to provide for the exercise of this Warrant. 

5. Notices of Record Date, etc. In the event the Company shall take a record of the holders of any of its Common Stock for the
purpose (a) of entitling or enabling them to receive any dividend or other distribution, or to receive any right to subscribe for or purchase any shares of stock of any class or any other securities, or to receive any other right; (b) of
any capital reorganization of the Company, any reclassification of the stock of the Company, any consolidation or merger of the Company with or into another corporation (other than a consolidation or merger in which the Company is the surviving
entity and its Common Stock is not converted into or exchanged for any other securities or property), or any transfer of all or substantially all of the assets of the Company; or (c) of the voluntary or involuntary dissolution, liquidation or
winding-up of the Company; then, and in each such case, the Company will mail or cause to be mailed to the Holder a notice specifying, as the case may be, (x) the record date for such dividend, distribution or right, and the amount and
character of such dividend, distribution or right, or (y) the effective date on which such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation or winding-up is to take place, and the time, if any is to be
fixed, as of which the holders of record of Common Stock of the Company shall be entitled to exchange their shares for securities or other property deliverable upon such reorganization, reclassification, consolidation, merger, transfer, dissolution,
liquidation or winding-up. Such notice shall be mailed at least ten days prior to the record date or effective date for the event specified in such notice. 
 6. Exchange of Warrant. Upon the surrender by the Holder, properly endorsed, to the Company at the principal office of the Company, the Company will issue and deliver to or upon the order of such
Holder, at the Company’s expense, a new Warrant or Warrants of like tenor, in the name of the Holder or as the Holder may direct, without charge for any issuance or transfer tax or other cost incurred by the Company, calling in the aggregate on
the face or faces thereof for the number of shares of capital stock (or other securities, cash and/or property) then issuable upon exercise of this Warrant. The Company will at no time close its transfer books against the transfer of any Warrant
Shares issued or issuable upon the exercise of this Warrant in any manner which interferes with the timely exercise of this Warrant. 
 7. Replacement of Warrant. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and (in the case of loss, theft or
destruction) upon delivery of an indemnity agreement (with surety if reasonably required) in an amount reasonably satisfactory to the Company, or (in the case of mutilation) upon surrender and cancellation of this Warrant, the Company will issue, in
lieu thereof, a new Warrant of like tenor. Any such new Warrant executed and delivered shall constitute an additional contractual obligation on the part of the Company, whether or not the Warrant so lost, stolen, destroyed or mutilated shall be at
any time enforceable by anyone. 
 8. Transfer of Warrant. This Warrant and all rights hereunder are not transferable, in
whole or in part, absent the prior written consent of the Company; provided, however, that the foregoing notwithstanding, this Warrant may be transferred, upon surrender of this Warrant with a properly executed assignment (in the form
of Exhibit II hereto) to the Company at its address set forth below (or at such other address as it may designate by notice in writing to the Holder), to an affiliate or family member of Holder, or by testate or intestate succession. 

  
 - 3 -

 9. Miscellaneous. 

9.1 Expiration. This Warrant shall expire on the Expiration Date. 

9.2 Restrictive Legend. This Warrant, any Warrant issued upon transfer of this Warrant and any shares of Common Stock issued upon
exercise of this Warrant or any portion thereof shall be imprinted with substantially the following legend, in addition to any legends required under applicable state securities laws: 

“THE SECURITIES REPRESENTED BY AND UNDERLYING THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“ACT”), OR UNDER ANY APPLICABLE STATE SECURITIES LAWS. SUCH SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A CURRENT AND EFFECTIVE REGISTRATION STATEMENT
UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS WITH RESPECT TO SUCH SECURITIES, OR AN OPINION SATISFACTORY TO THE ISSUER AND ITS COUNSEL TO THE EFFECT THAT SUCH REGISTRATION IS NOT REQUIRED.” 

9.3 No Voting Rights. Nothing contained in this Warrant shall be construed as conferring upon Holder by virtue of holding this
Warrant (i) the right to vote or to consent as a shareholder in respect of meetings of shareholders for the election of directors of the Company or any other matter, (ii) the right to receive dividends except as set forth in
Section 3, or (iii) any other rights as a shareholder of the Company. 
 9.4 Modification And Waiver. This
Warrant and any provision hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the party against which enforcement is sought. 
 9.5 Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall be a Saturday or a Sunday or shall
be a legal holiday, then such action may be taken or such right may be exercised on the next succeeding day not a Saturday or a Sunday or a legal holiday. 
 9.6 Successors and Assigns. This Warrant shall be binding upon any successors or assigns of the Company. 
 Remainder of this page intentionally left blank. 

  
 - 4 -

 IN WITNESS WHEREOF, the Company has caused this Warrant to be executed and issued by its
duly authorized representative on the date first above written. 
  

			
	 AUTOGENOMICS, INC.

		
	 By:
	 	 /s/ Fareed Kureshy

		 	Fareed Kureshy
		 	Its President and CEO

 

	
	Address:
	
	 AutoGenomics, Inc.
 2980 Scott
Street
 Vista, CA 92081

	Attn: CEO

  
 - 5 -

 Schedule to Exhibit 10.20 

The following common stock warrants are substantially identical in all material respects to the representative warrant to which this
schedule is attached and which is filed as an exhibit to AutoGenomics, Inc.’s registration statement on Form S-1 (the “Registration Statement”), except as to the parties thereto, dates of issuances, number of warrant shares and
expiration dates set forth below. These other common stock warrants are not being filed with the Registration Statement, pursuant to Instruction 2 to Item 601 of Regulation S-K promulgated under the Securities Exchange Act of 1934, as amended.

  

							
	 Number
	  	 Holder
	  	Warrant
Shares	 
	E-01	  	Roland F. Smith	  	 	150,000	  
	E-02	  	Whitecap AG LLC	  	 	54,546	  
	E-03	  	PHD Investments II, LP	  	 	10,910	  
	E-04	  	Donald E. Pogorzelski Trust UA May 06, 1998, Donald E. Pogorzelski and Milica G. Pogorzelski, Trustees	  	 	109,091	  
	E-05	  	The Kentor Trust U/A DTD 09/18/2002, E.S. Kentor or A. Kentor, Trustee	  	 	39,000	  
	E-06	  	Laurence M. Demers	  	 	88,145	  
	E-07	  	Zurlo Investment Trust	  	 	31,187	  
	E-08	  	Omer Sen	  	 	545,456	  

  
 - 6 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}]]